Autism and Child Psychopathology Series Editor Johnny L. Matson Baton Rouge, Louisiana, USA More information about this series at http://www.springer.com/series/8665 Thompson E. Davis III • Susan W. White Thomas H. Ollendick Editors Handbook of Autism and Anxiety 2123 Editors Thompson E. Davis III Thomas H. Ollendick Department of Psychology Department of Psychology Louisiana State University Child Study Center Baton Rouge Virginia Tech Louisiana Blacksburg USA Virginia USA Susan W. White Department of Psychology Child Study Center Virginia Tech Blacksburg Virginia USA ISSN 2192-922X ISSN 2192-9238 (electronic) ISBN 978-3-319-06795-7 ISBN 978-3-319-06796-4 (eBook) DOI 10.1007/978-3-319-06796-4 Springer Cham Heidelberg New York Dordrecht London Library of Congress Control Number: 2014939564 © Springer International Publishing Switzerland 2014 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher’s location, in its cur- rent version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. While the advice and information in this book are believed to be true and accurate at the date of publication, neither the authors nor the editors nor the publisher can accept any legal responsi- bility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) To Allison, who is not only my wife but also my best friend. Her constant patience, kindness, encouragement, and love have been the key to my success professionally and personally. Thompson E. Davis III To my husband Brad White, who is always my biggest supporter, and my sons Alden and Calvin for providing perspective and unconditional love. Susan W. White To Mary, my wife, daughters Laurie and Katie, sons-in-law David and Billy, and grandchildren, Braden, Ethan, Calvin, Addison, Victoria, and William. Without them, life would be much less meaningful and enjoyable. Thomas H. Ollendick Foreword Thompson Davis III, Susan White, and Thomas Ollendick are to be con- gratulated for having produced an important edited volume which brings together the clinical and research aspects of two conditions: autism and anxiety disorders. These two conditions are given scholarly attention sepa- rately and together. Different contributors to this novel collection consider the diagnostic overlap between these two conditions, whether the tradi- tional treatment methods for anxiety disorders apply to autism, and what may account for the considerable comorbidity between autism and anxi- ety disorders. The issue of anxiety has for 70 years been neglected within autism spectrum conditions (ASC), and in this new book it is brought into central focus. ASC is also referred to as ASD (autism spectrum disorders) but some authors prefer the more neutral term “condition” to the more value-laden term “disorder.” ASC is a neurodevelopmental condition affecting social cognition alongside unusually narrow interest and difficulties in coping with change/a need for sameness. It is commonly accepted clinically that if you put a person with ASC (whether they have classic autism or Asperger Syndrome) into social situations that are unpredictable and unfamiliar, they will experience high levels of social anxiety. And as far as is known, this is true from the earli- est age and remains the case across the lifespan. This may be secondary to the social-cognitive deficits they have, since they report difficulties in “reading” other people’s behavior and show impairments on “theory of mind” tests. Such difficulties mean that interpreting and predicting other people’s behavior may be challenging for them and lead to confusion, and to social avoidance. Their anxiety may also be secondary to their difficulties in dealing with unpredictability and change more generally, separate to the social world, even if it is the case that most unexpected change comes from the social world. This book will push clinicians to ask some new questions. If one has a very anxious patient, could this be undiagnosed autism? To answer this would entail an assessment of domains (such as obsessional interests and social skills) that might otherwise be overlooked. Equally, if one has a patient with autism, might their anxiety be treated using methods such as systematic desensitization or cognitive behavioral therapy, or do such approaches need vii viii Foreword to be modified to be useful to a person with autism? Finally, what is the relationship between autism and anxiety, and do they co-occur because of a common neural substrate, for example, in amygdala dysfunction? This book will be of great value both clinician-scientists in both the autism and anxiety fields, and will do what any valuable book should do, which is to make connections that open up new questions, hopefully lead to new knowledge, and improved clinical practice. Autism Research Centre Simon Baron-Cohen Cambridge University Cambridge UK Preface It is currently an exciting, but turbulent, time for those studying, assessing, treating, and researching autism spectrum disorder (ASD). It is also a chal- lenging time for individuals with ASD and their families, as they grapple with the upshots of the recent changes in the DSM and what the diagnostic labels mean to them both personally and with respect to service procurement. For the last several decades, estimates of the prevalence of ASD have increasingly indicated the disorder is becoming more and more common, with rates of 1 in 1000 children in 1980, to 1 in 150 children in 2000 to 1 in 88 children as of 2008 (Centers for Disease Control and Prevention [CDC] 2013). As more research has been conducted, it has become clear that ASD is also a disorder that does not occur in isolation. Comorbidity with other psychopathologies has become the rule rather than the exception for those with ASD (Matson and Nebel-Schwalm 2007). Piggybacking the relative explosion in research on ASD has been the subsequent development and ongoing refinement of assessment and treatment methodologies. Amidst all of these changes, a great reorienting of the clinical compass also occurred in May 2013 with the release of the Diagnostic and Statistical Manual for Mental Disorders—5th edition ( DSM-5) and its changes in diagnostic criteria (e.g., collapsing the various Pervasive Developmental Disorders into one disorder) and with pronounce- ments from the National Institute of Mental Health (NIMH) with its strong endorsement of Research Domain Criteria (RDoC). This latter development has resulted in an increased movement away from research based solely on DSM-5 diagnostic research. In addition, ASD was not the only diagnosis to emerge as a changeling from the DSM-5 work groups: many longstanding diagnoses and diagnostic catego- ries were revised, including a number of anxiety disorders. Importantly, anxiety disorders have been found to be one of the most common comorbid conditions experienced by those with ASD. Beginning with the earliest observations of ASD, there appeared to be a connection between the constellation of social, communicative, and behavioral symptoms and fear and anxiety. Kanner (1943) recorded one mother’s description of her son as being “afraid of mechanical things; he runs from them. He used to be afraid of my egg beater, is perfectly petrified of my vacuum cleaner. Elevators are simply a terrifying experience to him. He is afraid of spinning toys” (pp. 222–223). White, Oswald, Ollendick, and Scahill (2009) have noted that the rate of anxiety disorders and symptoms in those with ASD is as high as 84 %. Previous guidelines, especially as applied to the assessment and treatment of children and adolescents (e.g., Davis et al. ix x Preface 2011; Silverman and Ollendick 2005) in those with anxiety disorders provided a rough vision for what might work and be modified to help those with ASD (Moree and Davis 2010). Moreover, recent reviews and discussions of ASD, anxiety, and how the two might be intertwined have proven influential (Davis 2012; Kerns and Kendall 2012; Ollendick and White 2012) and pushed the field beyond mere downward and lateral iterations of anxiety in otherwise typically developing individuals to work specifically focused on the intersec- tion of ASD and anxiety (Davis 2012). As a result, decades of research and myriad recent changes to our definitions and understanding of ASD make this an opportune time to evaluate the current state of the literature, elucidate and reinforce best practices, and speculate about the future of these two distinct, but oft intertwined psychopathologies. Seven decades after Kanner’s observations, the time seems right to begin to summarize all of these findings in light of new diagnostic and research guidelines. This volume has emerged largely by standing on the shoulders of those researchers and clinicians who have tirelessly worked to better understand and help those with ASD. We are pleased to have been able to secure contri- butions from many leaders in the field. Even so, in both editing and writing portions of this book, we have tried to create a volume that would be useful to clinical and academic professionals alike. This book has been organized to be a resource for researchers and educators (e.g., as a training volume) and for practitioners serving clients (e.g., to better understand current issues with anxiety comorbidity). To these ends, we have divided the volume into four broad parts. Part I focuses on laying the groundwork for understanding ASD and anxiety. The volume begins with an historical review of ASD from the past to the present, and then proceeds with chapters devoted to variability in ASD presentation. Anxiety disorders in those with and without ASD and other comorbidities are then introduced and subsequent chapters deal with the increasingly difficult job of disentangling ASD and anxiety—or if they should or even can be disentangled. Part I concludes with a chapter on where we believe the future of ASD and anxiety research lies, in understanding the complex etiologic and transdiagnostic processes involved in the ASD and anxiety interplay. Part II of the volume then introduces specific anxiety diag- noses for consideration alongside ASD symptoms. For example, the common quandaries of whether symptoms are consistent with ASD or obsessive- compulsive disorder, or social anxiety disorder, or phobia are discussed. Part III tackles common issues of ASD and anxiety assessment and treatment, as well as implementation issues within clinics and schools. Finally, we are very pleased to have three diverse perspectives represented in Part IV where we turn to commentaries on the new DSM-5 criteria and RDoC recommenda- tions. The future of ASD research and practice is highlighted in these final chapters. Thompson E. Davis III Susan W. White Thomas H. Ollendick Preface xi References American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington: American Psychiatric Publishing. Centers for Disease Control and Prevention. (June 27, 2013). Autism spectrum disorders (ASD): Data & statistics. from http://www.cdc.gov/ncbddd/autism/data.html. Davis III, T. E. (2012). Where to from here for ASD and anxiety? Lessons learned from child anxiety and the issue of DSM-5. Clinical Psychology: Science and Practice, 19, 358–363. Davis III, T. E., May, A. C., & Whiting, S. E. (2011). Evidence-based treatment of anxiety and phobia in children and adolescents: Current status and effects on the emotional response. Clinical Psychology Review, 31, 592–602. Kanner, L. (1943). Autistic disturbances of affective contact. Nervous Child, 2, 217–250. Kerns, C. M., & Kendall, P. C. (2012). The presentation and classification of anxiety in autism spectrum disorder. Clinical Psychology: Science & Practice, 19, 323–347. Matson, J. L., & Nebel-Schwalm, M. (2007). Comorbid psychopathology with autism spec- trum disorder in children: An overview. Research in Developmental Disabilities, 28, 341–352. Moree, B., & Davis III, T. E. (2010). Cognitive-behavioral therapy for anxiety in children diagnosed with Autism Spectrum Disorders: Modification trends. Research in Autism Spectrum Disorders, 4, 346–354. Ollendick, T. H., & White, S. W. (2012). The presentation and classification of anxiety in autism spectrum disorder: Where to from here? Clinical Psychology: Science and Prac- tice, 19, 352–355. doi:10.1111/cpsp.12013. Silverman, W. K., & Ollendick, T. H. (2005). Evidence-based assessment of anxiety and its disorders in children and adolescents. Journal of Clinical Child and Adolescent Psy- chology, 34, 380–411. White, S. W., Oswald, D., Ollendick, T. H., & Scahill, L. (2009). Anxiety in children and adolescents with autism spectrum disorders. Clinical Psychology Review, 29, 216–229. xi
Description: